Stock-Based Compensation (Tables)

9 Months Ended

Mar. 25, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 25, 2017 and March 26, 2016, respectively:

	Three Months Ended
	March 25, 2017								March 26, 2016
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	105	$	1,660	$	494	$	2,259	$	120	$	1,182	$	629	$	1,931
Research and development	462		7,602		1,251		9,315		895		7,587		1,522		10,004
Selling, general and administrative	296		5,820		609		6,725		795		4,507		638		5,940
Pre-tax stock-based compensation expense	$	863	$	15,082	$	2,354	$	18,299	$	1,810	$	13,276	$	2,789	$	17,875
Less: income tax effect							2,659								1,989
Net stock-based compensation expense							$	15,640							$	15,886

	Nine Months Ended
	March 25, 2017								March 26, 2016
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	440	$	5,000	$	1,491	$	6,931	$	735	$	5,140	$	1,808	$	7,683
Research and development	1,305		22,293		3,536		27,134		2,608		20,671		3,904		27,183
Selling, general and administrative	1,115		16,557		1,756		19,428		2,415		14,271		1,705		18,391
Pre-tax stock-based compensation expense	$	2,860	$	43,850	$	6,783	$	53,493	$	5,758	$	40,082	$	7,417	$	53,257
Less: income tax effect							8,551								8,046
Net stock-based compensation expense							$	44,942							$	45,211

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 25, 2017 and their activity for the nine months ended March 25, 2017:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 25, 2016	5,935,079		$	25.11
Options Granted	—		—
Options Exercised	(1,970,705	)	22.61
Options Cancelled	(351,285	)	25.50
Balance at March 25, 2017	3,613,089		$	26.26	2.6	$	69,109,520
Exercisable, March 25, 2017	2,473,039		$	25.27	2.3	$	49,684,566
Vested and expected to vest, March 25, 2017	3,576,218		$	26.23	2.6	$	68,414,258

(1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 25, 2017.

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]

The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 25, 2017 and their activity during the nine months ended March 25, 2017:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 25, 2016	6,620,813
Restricted stock units and other awards granted	2,132,967
Restricted stock units and other awards released	(1,380,533	)
Restricted stock units and other awards cancelled	(743,139	)
Balance at March 25, 2017	6,630,108		2.8	$	297,872,452
Outstanding and expected to vest, March 25, 2017	5,421,956		2.7	$	245,939,941

(1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 25, 2017.

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]

The following table summarizes the number of MSUs outstanding and expected to vest as of March 25, 2017 and their activity during the nine months ended March 25, 2017:

	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 25, 2016	673,532
Market stock units granted	308,432
Market stock units released	—
Market stock units cancelled	(128,520	)
Balance at March 25, 2017	853,444		2.9	$	38,712,220
Outstanding and expected to vest, March 25, 2017	677,094		2.8	$	30,712,962

(1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 25, 2017.

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]

The fair value of ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding:

	ESPP		ESPP
	Three Months Ended		Nine Months Ended
	March 25, 2017	March 26, 2016	March 25, 2017	March 26, 2016
Expected holding period (in years)	0.5	0.5	0.5	0.5
Risk-free interest rate	0.5%	0.2% - 0.4%	0.5% - 0.7%	0.1% - 0.4%
Expected stock price volatility	27.2% - 28.2%	24.2% - 33.1%	22.1% - 30.4%	21.8% - 33.1%
Dividend yield	3.5% - 3.6%	3.3% - 3.6%	3.4% - 3.6%	3.3% - 3.6%